Boston Scientific Inc. (BSX): Today's Featured Health Services Winner

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

Boston Scientific ( BSX) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole closed the day up 0.5%. By the end of trading, Boston Scientific rose 27 cents (5.2%) to $5.50 on heavy volume. Throughout the day, 52.5 million shares of Boston Scientific exchanged hands as compared to its average daily volume of 11.4 million shares. The stock ranged in a price between $5.18-$5.53 after having opened the day at $5.22 as compared to the previous trading day's close of $5.23. Other companies within the Health Services industry that increased today were: CombiMatrix Corporation ( CBMX), up 22%, BG Medicine ( BGMD), up 11.5%, NeuroMetrix ( NUROD), up 9.3%, and Bovie Medical Corporation ( BVX), up 7.9%.
  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. Boston Scientific has a market cap of $7.15 billion and is part of the health care sector. The company has a P/E ratio of -1.8, below the S&P 500 P/E ratio of 17.7. Shares are down 2.4% year to date as of the close of trading on Tuesday. Currently there are five analysts that rate Boston Scientific a buy, one analyst rates it a sell, and 15 rate it a hold.

TheStreet Ratings rates Boston Scientific as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, weak operating cash flow and generally disappointing historical performance in the stock itself.

On the negative front, St Jude Medical ( STJ), down 12.2%, Dynatronics Corporation ( DYNT), down 11.1%, Arrhythmia Research Technology ( HRT), down 9.1%, and Heartware International ( HTWR), down 8.8%, were all laggards within the health services industry with Thermo Fisher Scientific ( TMO) being today's health services industry laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

FREE for a limited time only: Get TheStreet Ratings #1 Stock Report NOW!.
null

If you liked this article you might like

Quants and Charts Agree That Boston Scientific is a Buy

Quants and Charts Agree That Boston Scientific is a Buy

Blizzard Pounds New York, Boston as 'Bomb Cyclone' Cripples East Coast Airports

Blizzard Pounds New York, Boston as 'Bomb Cyclone' Cripples East Coast Airports

Nvidia Is 1 of 30 Well-Known Stocks That Look Ready to Abruptly Change Direction

Nvidia Is 1 of 30 Well-Known Stocks That Look Ready to Abruptly Change Direction

Masco, Diplomat Pharmacy, Vail Resorts: 'Mad Money' Lightning Round

Masco, Diplomat Pharmacy, Vail Resorts: 'Mad Money' Lightning Round

What it Takes to Power This Bull: Cramer's 'Mad Money' Recap (Thursday 11/30/17)

What it Takes to Power This Bull: Cramer's 'Mad Money' Recap (Thursday 11/30/17)